Truist raised the firm’s price target on Cognex (CGNX) to $61 from $50 and keeps a Hold rating on the shares. The firm cites the company widely exceeding Q1 estimates on consensus sales, adjusted EBITDA, margins, and adjusted EPS, also stating that free cash flow remains strong with conversion expected north of 100%, the analyst tells investors in a research note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CGNX: